HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Facompré Selected Research

NB 506

9/2001Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Facompré Research Topics

Disease

3Leukemia
08/2001 - 04/2000
2Neoplasms (Cancer)
09/2001 - 07/2000
1Leukemia P388
09/2001

Drug/Important Bio-Agent (IBA)

3CamptothecinIBA
09/2001 - 04/2000
3Pharmaceutical PreparationsIBA
08/2001 - 04/2000
2Type II DNA Topoisomerases (Topoisomerase II)IBA
08/2001 - 07/2000
2DNA (Deoxyribonucleic Acid)IBA
07/2000 - 04/2000
1Type I DNA Topoisomerases (Topoisomerase I)IBA
09/2001
1NB 506IBA
09/2001
1homocamptothecinIBA
09/2001
1Irinotecan (Camptosar)FDA LinkGeneric
09/2001
1diflomotecanIBA
09/2001
1PoisonsIBA
08/2001
1DB358IBA
08/2001
1ImidazolinesIBA
08/2001
1Podophyllotoxin (Condylox)FDA LinkGeneric
07/2000
1Etoposide (VP 16)FDA LinkGeneric
07/2000
1Topoisomerase I InhibitorsIBA
04/2000
1Topoisomerase InhibitorsIBA
04/2000
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
04/2000